Condition
TDP-43 Proteinopathies clinical trials and research
As of November 12, 2026, Find a Trial lists 4 TDP-43 Proteinopathies clinical trials that are recruiting, at sites in 4 countries (most in Norway (1), Germany (1), Italy (1)). 1 was first registered in the last 30 days. By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 4Countries
Newest TDP-43 Proteinopathies clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Registering medical data and care outcomes for ALS, SMA, and other motor disorders | — | Berlin, State of Berlin | Recruiting | Oct 28, 2026 |
| Using a new PET tracer to measure TDP-43 protein in dementia and ALS | Early Phase 1 | Amsterdam | Recruiting | Mar 24, 2025 |
| Collecting data on neurodegenerative diseases progression markers | — | Cassino, Frosinone | Recruiting | Sep 19, 2024 |
| Impact of long-term ventilation support on ALS patients and their families | — | Bodø, Nordland and 8 other locations | Recruiting | Feb 27, 2023 |
All recruiting trials (4)
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
Using a new PET tracer to measure TDP-43 protein in dementia and ALS
This study is testing a new imaging method to see if it can safely detect a specific protein linked to frontotemporal dementia and ALS in the brains of people with these conditions and healthy volunteers.
-
Collecting data on neurodegenerative diseases progression markers
This study is trying to find new signs that can help doctors understand how neurodegenerative diseases like Parkinson's progress, so they can improve early treatment options for patients.
-
Impact of long-term ventilation support on ALS patients and their families
This study is testing how long-term breathing support affects the quality of life for people with ALS and their families.
Related topics
Quick answers
How many TDP-43 Proteinopathies clinical trials are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Norway (1 trial), Germany (1 trial), Italy (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.